News | News By Subject | News by Disease News By Date | Search News

Prostate cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Pfizer (PFE)'s Xtandi Flunks Late-Stage Study Against Johnson & Johnson (JNJ)'s Zytiga     12/16/2016
Taking a Closer Look at Nymox (NYMX)'s 'Overinflated' Prostate Drug Hype     8/29/2016
Struggling Tokai Pharma (TKAI) Nixes Enrollment in Mid-Stage Prostate Cancer Study     8/23/2016
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure     8/1/2016
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank     7/26/2016
ANI Pharma Snags FDA Approval and Immediate Launch of Nilutamide Tablets, The First Generic Competitor to Nilandron     7/18/2016
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion     3/7/2016
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation     12/28/2015
ASCO15: Exelixis (EXEL) Results for Drug Combo Buoy the Flailing SF Biotech     6/1/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial     4/17/2015
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine     3/5/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
ArQule, Inc. (ARQL) Reports Positive Phase 2 Tivantinib Prostate Cancer Trial Data     11/10/2014
AstraZeneca PLC (AZN)'s New Drug Olaparib May Also Work In Prostate Cancer     11/5/2014

News from Around the Web
Old Drug Gets New Trick For Prostate Cancer Treatment, Massachusetts General Hospital Reveals     2/3/2017
University of Pennsylvania Study Links Prostate Cancer Treatment To Dementia     10/14/2016
Ben Stiller Reveals Prostate Cancer Diagnosis, Says PSA Test Saved His Life     10/5/2016
New Prostate Cancer Tests Aim To Reduce The Death Rate     10/4/2016
New Prostate Cancer Test Strives To Slash Biopsies, Cleveland Diagnostics Reveals     7/7/2016
Robotic Rectum May Aid Prostate Cancer Diagnosis, Imperial College London Study     7/5/2016
University of Alabama at Birmingham Receives Cutting-Edge Robot To Diagnose And Support Treatment Of Prostate Cancer     6/9/2016
University of Virginia Researchers Work to Speed Prostate Cancer Detection     6/6/2016
BMI And Waist Size Linked To Prostate Cancer Risk, University of Oxford Study Finds     6/3/2016
BRCA Mutations May Play Role In Prostate Cancer, SUNY Upstate Medical University Study     5/11/2016
These Foods Linked To Aggressive Prostate Cancer? University of North Carolina Study     4/25/2016
This May Be Causing Depression, And Men Don't Even Know It, Brigham and Women's Hospital Study     4/12/2016
Urine Test Improves Prediction Of High-Grade Prostate Cancer, Columbia University Medical Center Study     4/1/2016
Low Vitamin D Linked To Aggressive Prostate Cancer, Northwestern University Study     3/2/2016
Baldness Linked To Risk For Prostate Cancer Deaths, National Cancer Institute Study     2/15/2016

Press Releases
Augmenix Release: Phase 3 Trial Data Show Use Of SpaceOAR Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment     2/24/2017
OncoGenex (OGXI) Release: Data Support Continued Exploration Of Hsp27 Inhibition In Bladder And Prostate Cancers     2/21/2017
Noble Capital Markets Initiates Research Coverage On ESSA Pharma     2/17/2017
Myriad Genetics (MYGN)’s Prolaris Test Significantly Improves The Risk Classification For One Third Of Men Diagnosed With Localized Prostate Cancer     2/17/2017
Genomic Health (GHDX) Release: Four New Studies Of Oncotype DX Genomic Prostate Score (GPS) Reconfirm Value Of Test In Guiding Early-Stage Prostate Cancer Risk Assessment And Treatment Selection     2/16/2017
AEterna Zentaris (AEZS) Announces Zoptrex Presentation In Prostate Cancer At 2017 Genitourinary Cancers Symposium     2/15/2017
Progenics (PGNX) Announces Initiation Of A Phase I Clinical Trial Of Its PSMA-Targeted Therapeutic Candidate 1095 For The Treatment Of Metastatic Prostate Cancer     2/14/2017
Blue Earth Diagnostics And Siemens (SI)' PETNET Solutions Increase Patient Access To Axumin (Fluciclovine F 18) Injection PET Imaging Agent For Suspected Recurrent Prostate Cancer     2/7/2017
Foresee Pharma Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer     1/27/2017
GenomeDx Biosciences Release: Diagnostic Company's Decipher Biopsy Demonstrates Ability To Predict Metastasis After Radiation And Androgen Deprivation Therapy In Prostate Cancer Patients     1/25/2017
Humanetics Release: Pharma Awarded Patent To Mitigate Erectile Dysfunction Associated With Prostate Cancer Radiotherapy     1/24/2017
Telix Pharma, ATLAB Pharma Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer     1/19/2017
Panacea Pharmaceuticals, Inc. Release: Company Initiates Phase I Study Of First-In-Class Cancer Vaccine Therapy Candidate In Patients With Persistent Prostate Cancer     1/17/2017
Augmenix Release: Company Announces Positive Three-Year Long-Term Data Highlighting Benefits Of Spaceoar Hydrogel Spacer For Patients With Prostate Cancer     1/12/2017
Debiopharm's Triptorelin 6-Month Formulation Receives Approval For The Treatment Of Central Precocious Puberty (CPP) In Europe     1/9/2017

//-->